Navigation Links
SemBioSys' GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
Date:3/14/2008

ve proven health benefits. Arcadia's high-GLA safflower oil is a convenient and cost-effective source of GLA compared to existing alternatives," said Andrew Baum, President and CEO of SemBioSys.

About SemBioSys Genetics Inc. (http://www.sembiosys.com)

Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology company developing protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company's lead pharmaceutical candidates are recombinant human insulin to serve the rapidly expanding global diabetes market and Apo AI, a next generation cardiovascular drug. In addition to its pharmaceutical products, SemBioSys is developing a series of non-pharmaceutical products addressing human topical, nutritional oils and agricultural biotechnology markets.

About Arcadia Biosciences, Inc.

Based in Davis, Calif., with additional facilities in Seattle, Wash. and Phoenix, Ariz., Arcadia Biosciences is an agricultural biotechnology company focused on the development of agricultural products that improve the environment and enhance human health. For more information visit http://www.arcadiabio.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions, the successful and timely completion o
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
8. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...tCall/ -- Jazz Pharmaceuticals,Inc. (Nasdaq: J...e presentation,planned for today at the Lazard Ca...e to the proximity of the release of preliminary t...nical trial of JZP-6 (sodium oxybate) for,the tre...ipates that it will release the preliminary top-li...
(Date:11/19/2008)...eneNews Limited (TSX: GEN), a company focused on d...y detection of diseases and personalized health ma...ian Colorectal Cancer Advisory Board. Drs. Lawrenc... Smith and Mr. Barry Stein will advise GeneNews on...Canadian commercialization of ColonSentry(TM), the...
(Date:11/18/2008)...(R) LLC is extremely proud to,announce the releas...system,for the Mac platform. RISLinQ(R) 4.0Mac pr...diology facilities presently using the Mac OS X pl...TLinQ, states, "The Mac OS X platform,is a world ...g system that,many radiologists and their staff h...
(Date:11/18/2008)...e/ -- Cascades Technologies, Inc. (CTi), a federal...d that it was chosen to provide a variety of web-b...earch Program. Working closely with prime contrac... (NYSE: SAI ) and the Blast Injury Research Prog...ical Research and Materiel Command (USAMRMC), CTi ...
Breaking Biology Technology:GeneNews appoints Canadian Colorectal Cancer Advisory Board 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 3PETLinQ Launches RISLinQ 4.0Mac on Mac OS X Platform 2Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program 2Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program 3
...le for businesses that don,t adapt easily to an en...ate branding. , ,Local businesses such as restaura...ed and outmarketed online by larger competitors. ,...rs, physicians, and consultants struggle to adapt ...ernet. , ,Commission-driven sales organizations su...
Milwaukee Rockwell Automation Inc. has increased the quarterly dividend on its common stock to 22.5 cents per share, up from 16.5 cents, effective May 16. , ,Chairman and CEO Keith Nosbusch said t
... county businesses will receive funding for their ...ment of Commerce Technology Assistance Grant pro... will receive $11,250 to assist in its development...any will use this award to finish a patent-filing ...ff, we have not had the benefit of WARF to compl...
...nics of raising capital for your business ", when ...company should do is prepare a business plan. The ...rivate placement memorandum (PPM), the disclosure .... , ,Once the company has a good draft of the bus...(e.g., the company management, attorneys, accounta...
Other Biology Technology:Succeeding online without a Web site 2Succeeding online without a Web site 3Succeeding online without a Web site 4Due diligence and corporate clean-up 2Due diligence and corporate clean-up 3Due diligence and corporate clean-up 4
(Date:11/19/2008)...compounds created by a University of Central Flori...ast cancer tumors. , Associate Professor James T...d of breast cancer tumors in tests on mice. The c...-causing protein called STAT3, and researchers hav...he compounds are very promising," Turkson said. "T...
(Date:11/19/2008)... most reliable indicators to predict that a person...nsulin resistance. Insulin is produced in the panc...hat glucose reaches several tissues and organs in ...haracterized by the lack of tissue response to ins...f insulin by the pancreas. When the pancreas does ...
(Date:11/18/2008)...less ButtKicker(R) Kit to be Released by Amazon.co...v. 17 The Guitammer Company announ...(R) Kit for home theater, gaming and music. The ne... do-it-yourself product for home theater and gamin...urniture to become part of an affordable "4-D" the...
(Date:11/18/2008)...SWICK, N.J. Families gathering around the Thanksg...e dish that,s been given some "upscale" breeding ...age-old staple will look or taste no different tha...ing growers increase production and improve fruit ...ing them meet the increasing year-round demand for...
Breaking Biology News(10 mins):2 new compounds show promise for eliminating breast cancer tumors 2Researchers at IRB Barcelona produce more data on key genes in diabetes 2Researchers at IRB Barcelona produce more data on key genes in diabetes 3Photos: Turn Your Couch into a 'Disney' Ride for Under $300 2Photos: Turn Your Couch into a 'Disney' Ride for Under $300 3Favorite Thanksgiving dish gets 'upscale' breeding 2Part of the in group 3F A surprising new strategy helps reduce unhealthy behaviors 25712 1Part of the in group 3F A surprising new strategy helps reduce unhealthy behaviors 25712 2Operations research promises continued gains for HIV treatment in resource limited countries 25709 1Operations research promises continued gains for HIV treatment in resource limited countries 25709 2Operations research promises continued gains for HIV treatment in resource limited countries 25709 3The big gulp 3A consumers avoid extremes in soda sizes 25706 1The big gulp 3A consumers avoid extremes in soda sizes 25706 2Actuaries to Host Forum on Public Pension Disclosures 25703 1Actuaries to Host Forum on Public Pension Disclosures 25703 2Actuaries to Host Forum on Public Pension Disclosures 25703 3
... the National Cancer Institute, a Wake Forest Univ... to improve the effectiveness of a drug that he d..., Waldemar Debinski, M.D., Ph.D., pioneered a met...BM) with less damage to healthy cells. The drug is...inski is working on its fourth generation in the l...
... effective way to screen drugs against Huntington,...and riluzole ?are most effective at keeping cells ... Southwestern Medical Center researchers report. ...untington,s disease models and some HD human trial...id Dr. Ilya Bezprozvanny, associate professor of p...
...nt form of good cholesterol provides significantly... than therapy using the "normal" HDL gene, accordi...chers at Cedars-Sinai Medical Center and reported ... College of Cardiology. , Apolipoprotein A-I is a...-density lipoprotein), the "good" cholesterol that...
...two key physical processes that lend spider silk i...ser to reality the long-sought goal of spinning ar...ould be used for artificial tendons and ligaments,...gineers have not managed to do what spiders do eff...r issue of the Journal of Experimental Biology, Ga...
Other Biology News:Scientist works to improve treatment for brain tumors 2Test reveals effectiveness of potential Huntington's disease drugs 2Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 2Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation 3MIT engineers probe spiders' polymer art 2MIT engineers probe spiders' polymer art 3MIT engineers probe spiders' polymer art 4
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048
LTQ XL Linear Ion Trap from Thermo Scientific
Biology Products: